Clinical Trial Update: Phase I Study of Aprotinin in Advanced Breast Cancer [Phase 1]

View source ↗

Summary

This update notes that a Phase I study of aprotinin for metastatic breast cancer was terminated. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aprotinin (aprotinin)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 1 | Status: TERMINATED